Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001881283 | SCV002141781 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-02-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002334792 | SCV002643700 | uncertain significance | Cardiovascular phenotype | 2023-06-12 | criteria provided, single submitter | clinical testing | The p.P1726S variant (also known as c.5176C>T), located in coding exon 30 of the FLNC gene, results from a C to T substitution at nucleotide position 5176. The proline at codon 1726 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |